Your browser is no longer supported. Please, upgrade your browser.
Settings
MRNA [NASD]
Moderna, Inc.
Index- P/E- EPS (ttm)-1.94 Insider Own2.50% Shs Outstand396.81M Perf Week6.31%
Market Cap53.58B Forward P/E9.48 EPS next Y14.87 Insider Trans-55.69% Shs Float356.19M Perf Month8.61%
Income-747.10M PEG- EPS next Q3.21 Inst Own50.40% Short Float4.20% Perf Quarter22.44%
Sales803.40M P/S66.69 EPS this Y-26.10% Inst Trans-2.18% Short Ratio1.34 Perf Half Y94.72%
Book/sh6.45 P/B21.85 EPS next Y-31.96% ROA-17.00% Target Price174.25 Perf Year334.67%
Cash/sh12.12 P/C11.63 EPS next 5Y16.80% ROE-30.20% 52W Range31.71 - 189.26 Perf YTD34.89%
Dividend- P/FCF27.34 EPS past 5Y- ROI-28.40% 52W High-25.16% Beta-
Dividend %- Quick Ratio1.40 Sales past 5Y- Gross Margin99.00% 52W Low346.68% ATR8.67
Employees1300 Current Ratio1.40 Sales Q/Q3960.80% Oper. Margin-95.00% RSI (14)53.14 Volatility5.48% 6.01%
OptionableYes Debt/Eq0.05 EPS Q/Q-86.50% Profit Margin-93.00% Rel Volume0.75 Prev Close140.92
ShortableYes LT Debt/Eq0.04 EarningsFeb 25 BMO Payout- Avg Volume11.18M Price141.64
Recom2.60 SMA203.96% SMA50-5.35% SMA20035.59% Volume581,139 Change0.51%
Feb-01-21Downgrade BofA Securities Neutral → Underperform
Dec-16-20Downgrade Morgan Stanley Overweight → Equal-Weight $150
Dec-16-20Downgrade Jefferies Buy → Hold $90 → $150
Dec-09-20Downgrade Needham Buy → Hold
Nov-23-20Initiated Wells Fargo Equal Weight $92
Nov-17-20Downgrade BMO Capital Markets Outperform → Market Perform $109
Sep-08-20Downgrade SVB Leerink Mkt Perform → Underperform $58 → $41
Jul-23-20Initiated SVB Leerink Mkt Perform
Jul-20-20Downgrade JP Morgan Overweight → Neutral $89
Jul-13-20Initiated Jefferies Buy $90
Jun-30-20Initiated Argus Buy $80
Jun-08-20Initiated Barclays Overweight $68
Apr-30-20Initiated BMO Capital Markets Outperform $83
Mar-05-20Downgrade BofA/Merrill Buy → Neutral $32
Dec-03-19Resumed BofA/Merrill Buy
Oct-25-19Initiated ROTH Capital Buy $24
Apr-05-19Initiated Chardan Capital Markets Buy $40
Apr-12-21 04:30AM  
03:41AM  
Apr-10-21 10:29AM  
06:30AM  
Apr-09-21 05:23PM  
04:23PM  
04:20PM  
01:39PM  
12:12PM  
11:46AM  
11:30AM  
09:55AM  
09:55AM  
09:11AM  
08:00AM  
06:00AM  
05:52AM  
Apr-08-21 05:00PM  
04:53PM  
03:23PM  
01:23PM  
07:30AM  
04:50AM  
Apr-07-21 07:27PM  
02:23PM  
02:05PM  
02:03PM  
01:26PM  
12:28PM  
12:20PM  
11:18AM  
11:01AM  
10:11AM  
09:36AM  
09:36AM  
08:00AM  
07:42AM  
07:00AM  
07:00AM  
06:33AM  
06:30AM  
06:01AM  
06:00AM  
05:29AM  
05:27AM  
05:18AM  
01:56AM  
01:37AM  
Apr-06-21 02:43PM  
01:29PM  
01:14PM  
12:00PM  
11:09AM  
10:41AM  
09:53AM  
09:00AM  
08:00AM  
07:47AM  
06:57AM  
06:46AM  
06:26AM  
06:24AM  
05:23AM  
02:45AM  
Apr-05-21 07:24PM  
04:14PM  
02:06PM  
01:23PM  
11:40AM  
07:45AM  
07:18AM  
05:37AM  
02:05AM  
Apr-04-21 08:00AM  
Apr-03-21 10:48AM  
08:00AM  
06:00AM  
06:00AM  
Apr-02-21 03:02PM  
09:44AM  
09:32AM  
07:03AM  
06:21AM  
Apr-01-21 11:25PM  
11:19PM  
10:30PM  
10:23PM  
09:45PM  
05:45PM  
02:46PM  
02:07PM  
01:46PM  
01:24PM  
12:01PM  
11:07AM  
10:00AM  
09:34AM  
08:13AM  
07:07AM  
06:50AM  
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of COVID-19 vaccine; and Catalent Inc., Laboratorios Farmaceuticos Rovi, S.A., and Recipharm for fill-finish manufacturing of its COVID-19 vaccine candidate. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HENDERSON LORI M.General Counsel and SecretaryApr 08Option Exercise20.936,600138,1387,501Apr 09 04:27 PM
Bancel StephaneChief Executive OfficerApr 08Sale132.8510,0001,328,5007,464,880Apr 09 04:15 PM
HENDERSON LORI M.General Counsel and SecretaryApr 08Sale132.856,600876,810901Apr 09 04:27 PM
Andres JuanSee remarksApr 07Option Exercise12.215,00061,0505,000Apr 08 04:11 PM
Andres JuanSee remarksApr 07Sale131.635,000658,1500Apr 08 04:11 PM
Bancel StephaneChief Executive OfficerApr 07Sale131.639,0001,184,6706,369,868Apr 09 04:15 PM
HENDERSON LORI M.General Counsel and SecretaryApr 06Option Exercise20.936,600138,1387,501Apr 08 04:09 PM
HENDERSON LORI M.General Counsel and SecretaryApr 06Sale130.016,600858,066901Apr 08 04:09 PM
Hoge StephenPresidentApr 05Option Exercise0.9920,00019,8001,629,597Apr 06 04:07 PM
Andres JuanSee remarksApr 05Option Exercise12.215,00061,0505,000Apr 06 04:11 PM
Zaks Tal ZviChief Medical OfficerApr 05Option Exercise12.215,00061,0505,000Apr 06 04:13 PM
Bancel StephaneChief Executive OfficerApr 05Sale129.7711,0461,433,41788,384Apr 06 04:05 PM
Hoge StephenPresidentApr 05Sale132.6320,0002,652,6001,609,597Apr 06 04:07 PM
Andres JuanSee remarksApr 05Sale132.635,000663,1500Apr 06 04:11 PM
Zaks Tal ZviChief Medical OfficerApr 05Sale129.715,000648,5300Apr 06 04:13 PM
HENDERSON LORI M.General Counsel and SecretaryApr 01Option Exercise20.936,600138,1387,501Apr 02 10:30 AM
HENDERSON LORI M.General Counsel and SecretaryApr 01Sale132.516,600874,566901Apr 02 10:30 AM
Bancel StephaneChief Executive OfficerApr 01Sale132.5110,0001,325,1007,474,880Apr 02 10:34 AM
Bancel StephaneChief Executive OfficerMar 31Sale121.109,0001,089,9006,380,868Apr 02 10:34 AM
AFEYAN NOUBARDirectorMar 31Sale121.074,888591,8109,116,657Mar 31 08:00 PM
AFEYAN NOUBARDirectorMar 30Sale118.972,112,795251,366,6809,121,545Mar 31 08:00 PM
Andres JuanSee remarksMar 29Option Exercise12.215,00061,0505,000Mar 30 04:51 PM
AFEYAN NOUBARDirectorMar 29Sale124.601,635,122203,734,06411,234,340Mar 31 08:00 PM
Andres JuanSee remarksMar 29Sale130.055,000650,2500Mar 30 04:51 PM
Bancel StephaneChief Executive OfficerMar 26Sale132.7611,0461,466,46499,430Mar 30 04:51 PM
HENDERSON LORI M.General Counsel and SecretaryMar 25Option Exercise20.936,600138,1387,501Mar 26 04:33 PM
HENDERSON LORI M.General Counsel and SecretaryMar 25Sale126.886,600837,408901Mar 26 04:33 PM
Bancel StephaneChief Executive OfficerMar 25Sale126.8810,0001,268,8007,484,880Mar 26 04:34 PM
Hoge StephenPresidentMar 24Option Exercise10.905,00054,5001,614,597Mar 25 04:13 PM
Andres JuanSee remarksMar 24Option Exercise12.215,00061,0505,000Mar 25 04:12 PM
Bancel StephaneChief Executive OfficerMar 24Sale137.079,0001,233,6306,391,868Mar 26 04:34 PM
Hoge StephenPresidentMar 24Sale137.075,000685,3501,609,597Mar 25 04:13 PM
Andres JuanSee remarksMar 24Sale137.075,000685,3500Mar 25 04:12 PM
Hoge StephenPresidentMar 23Option Exercise4.2915,00064,4001,624,597Mar 25 04:13 PM
HENDERSON LORI M.General Counsel and SecretaryMar 23Option Exercise20.936,600138,1387,501Mar 25 04:11 PM
Hoge StephenPresidentMar 23Sale142.0815,0002,131,2681,609,597Mar 25 04:13 PM
HENDERSON LORI M.General Counsel and SecretaryMar 23Sale145.556,600960,630901Mar 25 04:11 PM
Zaks Tal ZviChief Medical OfficerMar 22Option Exercise20.931,19925,0951,199Mar 23 04:19 PM
Andres JuanSee remarksMar 22Option Exercise12.215,00061,0505,000Mar 23 04:15 PM
Zaks Tal ZviChief Medical OfficerMar 22Sale144.821,199173,6400Mar 23 04:19 PM
Andres JuanSee remarksMar 22Sale144.195,000720,9500Mar 23 04:15 PM
Bancel StephaneChief Executive OfficerMar 19Sale142.6411,0461,575,547110,476Mar 23 04:07 PM
HENDERSON LORI M.General Counsel and SecretaryMar 18Option Exercise25.776,600170,0587,501Mar 19 05:18 PM
HENDERSON LORI M.General Counsel and SecretaryMar 18Sale144.396,600952,974901Mar 19 05:18 PM
Bancel StephaneChief Executive OfficerMar 18Sale144.3910,0001,443,9007,494,880Mar 19 05:16 PM
Andres JuanSee remarksMar 17Option Exercise12.215,00061,0505,000Mar 18 04:08 PM
Bancel StephaneChief Executive OfficerMar 17Sale149.789,0001,348,0206,402,868Mar 19 05:16 PM
Andres JuanSee remarksMar 17Sale149.785,000748,9000Mar 18 04:08 PM
HENDERSON LORI M.General Counsel and SecretaryMar 16Option Exercise25.936,600171,1387,501Mar 18 04:11 PM
HENDERSON LORI M.General Counsel and SecretaryMar 16Sale148.506,600980,100901Mar 18 04:11 PM
Hoge StephenPresidentMar 15Option Exercise4.2915,00064,4001,624,597Mar 16 04:05 PM
Zaks Tal ZviChief Medical OfficerMar 15Option Exercise20.9110,034209,78310,034Mar 16 04:07 PM
Andres JuanSee remarksMar 15Option Exercise12.215,00061,0505,000Mar 16 04:03 PM
Andres JuanSee remarksMar 15Sale137.005,000685,0000Mar 16 04:03 PM
Hoge StephenPresidentMar 15Sale137.0015,0002,055,0001,609,597Mar 16 04:05 PM
Zaks Tal ZviChief Medical OfficerMar 15Sale140.6810,0341,411,5350Mar 16 04:07 PM
Hoge StephenPresidentMar 12Option Exercise10.905,00054,5001,614,597Mar 16 04:05 PM
Hoge StephenPresidentMar 12Sale134.045,000670,2001,609,597Mar 16 04:05 PM
Bancel StephaneChief Executive OfficerMar 12Sale135.7311,0461,499,289121,522Mar 15 04:10 PM
HENDERSON LORI M.General Counsel and SecretaryMar 11Option Exercise25.936,600171,1387,501Mar 12 05:53 PM
HENDERSON LORI M.General Counsel and SecretaryMar 11Sale133.296,600879,714901Mar 12 05:53 PM
Bancel StephaneChief Executive OfficerMar 11Sale133.2910,0001,332,9007,504,880Mar 12 05:55 PM
Andres JuanSee remarksMar 10Option Exercise12.215,00061,0505,000Mar 11 04:54 PM
Bancel StephaneChief Executive OfficerMar 10Sale133.249,0001,199,1606,413,868Mar 12 05:55 PM
Andres JuanSee remarksMar 10Sale133.245,000666,2000Mar 11 04:54 PM
HENDERSON LORI M.General Counsel and SecretaryMar 09Option Exercise25.936,600171,1387,501Mar 10 04:03 PM
HENDERSON LORI M.General Counsel and SecretaryMar 09Sale127.116,600838,926901Mar 10 04:03 PM
Zaks Tal ZviChief Medical OfficerMar 08Option Exercise18.1116,478298,44616,478Mar 10 04:01 PM
Andres JuanSee remarksMar 08Option Exercise12.215,00061,0505,000Mar 10 04:02 PM
Andres JuanSee remarksMar 08Sale129.415,000647,0500Mar 10 04:02 PM
Zaks Tal ZviChief Medical OfficerMar 08Sale128.5916,4782,118,8630Mar 10 04:01 PM
Bancel StephaneChief Executive OfficerMar 05Sale128.1811,0461,415,858132,568Mar 08 05:12 PM
HENDERSON LORI M.General Counsel and SecretaryMar 04Option Exercise25.936,600171,1387,501Mar 05 04:28 PM
Bancel StephaneChief Executive OfficerMar 04Sale128.5810,0001,285,8007,514,880Mar 05 04:15 PM
HENDERSON LORI M.General Counsel and SecretaryMar 04Sale128.586,600848,628901Mar 05 04:28 PM
Andres JuanSee remarksMar 03Option Exercise12.215,00061,0505,000Mar 04 04:15 PM
Hoge StephenPresidentMar 03Option Exercise0.9910,0009,9001,619,597Mar 04 04:18 PM
Bancel StephaneChief Executive OfficerMar 03Sale145.609,0001,310,4006,424,868Mar 05 04:15 PM
Andres JuanSee remarksMar 03Sale145.605,000728,0000Mar 04 04:15 PM
Hoge StephenPresidentMar 03Sale145.6010,0001,456,0001,609,597Mar 04 04:18 PM
HENDERSON LORI M.General Counsel and SecretaryMar 02Option Exercise25.936,600171,1387,501Mar 04 04:13 PM
Hoge StephenPresidentMar 02Option Exercise0.9910,0009,9001,619,597Mar 04 04:18 PM
HENDERSON LORI M.General Counsel and SecretaryMar 02Sale153.776,6001,014,882901Mar 04 04:13 PM
Hoge StephenPresidentMar 02Sale153.7710,0001,537,7001,609,597Mar 04 04:18 PM
Andres JuanSee remarksMar 01Option Exercise12.215,00061,0505,000Mar 02 04:08 PM
Zaks Tal ZviChief Medical OfficerMar 01Option Exercise13.2110,000132,15010,000Mar 02 04:15 PM
Andres JuanSee remarksMar 01Sale153.845,000769,2000Mar 02 04:08 PM
Zaks Tal ZviChief Medical OfficerMar 01Sale150.4510,0001,504,5180Mar 02 04:15 PM
Bancel StephaneChief Executive OfficerFeb 26Sale154.7011,0461,708,845143,614Mar 01 04:11 PM
Bancel StephaneChief Executive OfficerFeb 25Sale150.8910,0001,508,9007,524,880Feb 26 04:49 PM
AFEYAN NOUBARDirectorFeb 24Sale146.191,753,697256,378,92412,869,462Feb 24 08:31 PM
Bancel StephaneChief Executive OfficerFeb 24Sale150.419,0001,353,6906,434,868Feb 26 04:49 PM
Hoge StephenPresidentFeb 24Sale150.415,000752,0501,609,597Feb 25 05:54 PM
Hoge StephenPresidentFeb 23Option Exercise0.9910,0009,9001,629,597Feb 25 05:54 PM
AFEYAN NOUBARDirectorFeb 23Sale145.352,947,638428,433,18514,623,159Feb 24 08:30 PM
Hoge StephenPresidentFeb 23Sale147.0815,0002,206,2731,614,597Feb 25 05:54 PM
Zaks Tal ZviChief Medical OfficerFeb 22Option Exercise12.215,00061,0505,000Feb 24 04:08 PM
Andres JuanSee remarksFeb 22Option Exercise12.215,00061,0505,000Feb 24 04:16 PM
Andres JuanSee remarksFeb 22Sale166.635,000833,1500Feb 24 04:16 PM
Zaks Tal ZviChief Medical OfficerFeb 22Sale164.845,000824,1960Feb 24 04:08 PM